Abstract
Myelination defects in the central nervous system (CNS) are associated with various psychiatric disorders, including drug addiction. As these disorders are often observed in individuals prenatally exposed to cigarette smoking, we tested the hypothesis that such exposure impairs central myelination in adolescence, an important period of brain development and the peak age of onset of psychiatric disorders. Pregnant Sprague Dawley rats were treated with nicotine (3 mg kg−1 per day; gestational nicotine (GN)) or gestational saline via osmotic mini pumps from gestational days 4–18. Both male and female offsprings were killed on postnatal day 35 or 36, and three limbic brain regions, the prefrontal cortex (PFC), caudate putamen and nucleus accumbens, were removed for measurement of gene expression and determination of morphological changes using quantitative real-time PCR (qRT-PCR) array, western blotting and immunohistochemical staining. GN altered myelin gene expression at both the mRNA and protein levels, with striking sex differences. Aberrant expression of myelin-related transcription and trophic factors was seen in GN animals, which correlated highly with the alterations in the myelin gene expression. These correlations suggest that these factors contribute to GN-induced alterations in myelin gene expression and also indicate abnormal function of oligodendrocytes (OLGs), the myelin-producing cells in the CNS. It is unlikely that these changes are attributable solely to an alteration in the number of OLGs, as the cell number was changed only in the PFC of GN males. Together, our findings suggest that abnormal brain myelination underlies various psychiatric disorders and drug abuse associated with prenatal exposure to cigarette smoke.
Highlights
Maternal smoking during pregnancy (MSDP) has been associated with a number of neuropsychiatric disorders in the offspring, such as attention-deficit hyperactivity disorder, conduct disorder, depression, autism and drug addiction.[1]
In males (Figure 2a), gestational nicotine (GN) increased the expression of myelin basic protein (Mbp), myelin-associated oligodendrocytic basic protein (Mobp), proteolipid protein 1 (Plp1), myelin-associated glycoprotein (Mag), gap junction membrane channel protein epsilon 1 (Gje1), gap junction protein alpha 12, 47 kDa (Gjc2) and claudin 11 (Cldn[11]; Po0.05 for each gene)
The GN treatment had no effects on glial fibrillary acidic protein (Gfap), chondroitin sulfate proteoglycan 4 (Cspg4) or ionized calcium-binding adaptor molecule 1 (Iba1), the markers for astrocytes, synantocytes and microglia, respectively, in either males or females (Figures 2c and d)
Summary
Maternal smoking during pregnancy (MSDP) has been associated with a number of neuropsychiatric disorders in the offspring, such as attention-deficit hyperactivity disorder, conduct disorder, depression, autism and drug addiction.[1] Sexual dimorphism has been observed in MSDP-induced neuropsychiatric disorders. Boys exposed to MSDP are more likely to develop conduct disorder than nonexposed individuals, whereas girls showed a greater risk of becoming drug dependent.[2] Adolescence is a critical period of brain development and the peak age of onset of psychiatric disorders,[3,4] and our recent studies have shown that gestational nicotine (GN) exposure impairs brain development during adolescence.[5,6]. In addition to increasing the conduction velocity of action potentials,[12] the OLGs synthesize neurotrophic factors, support neuronal survival and modulate neurotransmission.[13,14,15]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.